Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways (Q38790660)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 February 2016

Language	Label	Description	Also known as
English	Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways	scientific article published on 26 February 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jochen Rössler

3

0 references

author name string

M Harsha Raj

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

B Yashaswini

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Bharathi P Salimath

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

26 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

578-593

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Therapeutic potential of nitric oxide in cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Following a TRAIL: update on a ligand and its five receptors

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Resistance to TRAIL and how to surmount it.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Mcl-1: a gateway to TRAIL sensitization.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Emerging roles of anacardic acid and its derivatives: a pharmacological overview

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Anti-metastatic action of anacardic acid targets VEGF-induced signalling pathways in epithelial to mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Receptor-specific targeting with liposomes in vitro based on sterol-PEG(1300) anchors

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Death and anti-death: tumour resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death rec

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Potential biological applications of bio-based anacardic acids and their derivatives

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Targeting death-inducing receptors in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

p53 upregulates death receptor 4 expression through an intronic p53 binding site

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: evidence for the role of c-Jun N-terminal kinase activation.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

The complexity of mitogen-activated protein kinases (MAPKs) made simple

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

TRAIL and cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1223-8

21 January 2018

Identifiers

10.1007/S10495-016-1223-8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38790660&oldid=2202074023"